DaVita HealthCare Partners Inc (DVA)

Payables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cost of revenue (ttm) US$ in thousands 2,245,510 2,196,458 2,191,013 2,129,720 2,087,799 2,011,506 1,915,202 1,896,587 1,875,950 1,721,955 1,804,413 1,810,218 1,781,346 1,874,747 1,867,238 1,821,233 1,843,356 1,871,690 1,815,483 1,802,182
Payables US$ in thousands 514,533 435,417 427,894 447,969 479,780 417,139 402,308 433,137 402,049 387,712 376,264 348,105 434,253 388,504 357,283 340,092 403,840 332,136 388,955 365,192
Payables turnover 4.36 5.04 5.12 4.75 4.35 4.82 4.76 4.38 4.67 4.44 4.80 5.20 4.10 4.83 5.23 5.36 4.56 5.64 4.67 4.93

December 31, 2023 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $2,245,510K ÷ $514,533K
= 4.36

The payables turnover ratio for DaVita Inc has consistently been reported as 0.00 for each quarter from Q1 2022 to Q4 2023. This indicates that the company is not efficiently managing its accounts payables in relation to its purchases. A payables turnover ratio of 0.00 suggests that DaVita Inc is not paying its suppliers or vendors in a timely manner, potentially leading to strained relationships with creditors and suppliers. Further investigation into the reasons behind this consistently low ratio is warranted to determine any potential risks or issues related to the company's payables management practices.


Peer comparison

Dec 31, 2023

Company name
Symbol
Payables turnover
DaVita HealthCare Partners Inc
DVA
4.36
Progyny Inc
PGNY
8.18
Sotera Health Co
SHC
6.65